The role of eukaryotic and prokaryotic ABC transporter family in failure of chemotherapy R El-Awady, E Saleh, A Hashim, N Soliman, A Dallah, A Elrasheed, ... Frontiers in pharmacology 7, 535, 2017 | 160 | 2017 |
Recent advances in management of COVID-19: A review S Mouffak, Q Shubbar, E Saleh, R El-Awady Biomedicine & Pharmacotherapy 143, 112107, 2021 | 99 | 2021 |
Inhibition of exosome release by ketotifen enhances sensitivity of cancer cells to doxorubicin FM Khan, E Saleh, H Alawadhi, R Harati, WH Zimmermann, R El-Awady Cancer biology & therapy 19 (1), 25-33, 2018 | 76 | 2018 |
Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy RA El-Awady, F Hersi, H Al-Tunaiji, EM Saleh, AHA Abdel-Wahab, ... Cancer biology & therapy 16 (7), 1056-1070, 2015 | 59 | 2015 |
Antagonism between curcumin and the topoisomerase II inhibitor etoposide: a study of DNA damage, cell cycle regulation and death pathways EM Saleh, RA El-awady, NA Eissa, WM Abdel-Rahman Cancer biology & therapy 13 (11), 1058-1071, 2012 | 44 | 2012 |
Interaction of celecoxib with different anti-cancer drugs is antagonistic in breast but not in other cancer cells RA El-Awady, EM Saleh, M Ezz, AM Elsayed Toxicology and applied pharmacology 255 (3), 271-286, 2011 | 44 | 2011 |
Ginger: From serving table to salient therapy V Menon, M Elgharib, R El-awady, E Saleh Food Bioscience 41, 100934, 2021 | 35 | 2021 |
Inhibition of SHP2 by new compounds induces differential effects on RAS/RAF/ERK and PI3K/AKT pathways in different cancer cell types CG Vazhappilly, E Saleh, W Ramadan, V Menon, AM Al-Azawi, H Tarazi, ... Investigational new drugs 37, 252-261, 2019 | 34 | 2019 |
Predictive markers for the response to 5-fluorouracil therapy in cancer cells: Constant-field gel electrophoresis as a tool for prediction of response to 5-fluorouracil-based … EM Saleh, RA El-Awady, N Anis Oncology letters 5 (1), 321-327, 2013 | 34 | 2013 |
Targeting DNA double-strand break repair: is it the right way for sensitizing cells to 5-fluorouracil? RA El-Awady, EM Saleh, J Dahm-Daphi Anti-cancer drugs 21 (3), 277-287, 2010 | 27 | 2010 |
No correlation between radiosensitivity or double-strand break repair capacity of normal fibroblasts and acute normal tissue reaction after radiotherapy of breast cancer patients RA El-Awady, M Mahmoud, EM Saleh, HA El-Baky, M Lotayef, ... International journal of radiation biology 81 (7), 501-508, 2005 | 27 | 2005 |
Interplay between epigenetics, expression of estrogen receptor-α, HER2/ERBB2 and sensitivity of triple negative breast cancer cells to hormonal therapy WS Ramadan, CG Vazhappilly, EM Saleh, V Menon, AM AlAzawi, ... Cancers 11 (1), 13, 2018 | 26 | 2018 |
Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells EM Saleh, RA El-Awady, MA Abdel Alim, AHA Abdel Wahab Cell biochemistry and biophysics 55, 95-105, 2009 | 25 | 2009 |
Apoptosis is the most efficient death-pathway in tumor cells after topoisomerase II inhibition. RA El-Awady, MM Ali, EM Saleh, FM Ghaleb Saudi medical journal 29 (4), 558-564, 2008 | 23 | 2008 |
The role of HDACs in the response of cancer cells to cellular stress and the potential for therapeutic intervention RK Alseksek, WS Ramadan, E Saleh, R El-Awady International Journal of Molecular Sciences 23 (15), 8141, 2022 | 19 | 2022 |
Induction of DNA damage, apoptosis and cell cycle perturbation mediate cytotoxic activity of new 5-aminosalicylate–4-thiazolinone hybrid derivatives WS Ramadan, EM Saleh, V Menon, CG Vazhappilly, HHM Abdu-Allah, ... Biomedicine & Pharmacotherapy 131, 110571, 2020 | 17 | 2020 |
Induction and repair of DNA double-strand breaks using constant-field gel electrophoresis and apoptosis as predictive markers for sensitivity of cancer cells to cisplatin EM Saleh, RA El-Awady, N Anis, N El-Sharkawy Biomedicine & Pharmacotherapy 66 (7), 554-562, 2012 | 17 | 2012 |
Epigenetic modulations in cancer: predictive biomarkers and potential targets for overcoming the resistance to topoisomerase I inhibitors MM Madkour, WS Ramadan, E Saleh, R El-Awady Annals of Medicine 55 (1), 2203946, 2023 | 15 | 2023 |
Effect of safranal on the response of cancer cells to topoisomerase I inhibitors: Does sequence matter? L Lozon, E Saleh, V Menon, WS Ramadan, A Amin, R El-Awady Frontiers in Pharmacology 13, 938471, 2022 | 11 | 2022 |
Inhibition of topoisomerase IIα sensitizes FaDu cells to ionizing radiation by diminishing DNA repair EM Saleh Tumor Biology 36, 8985-8992, 2015 | 10 | 2015 |